Ramsay-Hunt syndrome and subsequent sensory neuropathy as potential immune-related adverse events of nivolumab: a case report.
Takashi SakohMami KanzakiAtsushi MiyamotoSayaka MochizukiToshiyuki KakumotoKenichiro SatoYoshikazu UesakaKazuma KishiPublished in: BMC cancer (2019)
Our case presented with the comorbidity of RHS and subsequent ataxic sensory neuropathy after nivolumab therapy to whom IVIg was effective. Our case suggested the wide variability of possible neurological symptoms, and the potential usefulness of IVIg to sensory ataxic neuropathy, seen in cancer patients with ICI treatment.